0001225208-23-005815.txt : 20230512 0001225208-23-005815.hdr.sgml : 20230512 20230512161005 ACCESSION NUMBER: 0001225208-23-005815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230510 FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tsourapas Panagiotis CENTRAL INDEX KEY: 0001576945 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 23915736 MAIL ADDRESS: STREET 1: C/O COLGATE-PALMOLIVE COMPANY STREET 2: 300 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml X0407 4 2023-05-10 0000021665 COLGATE PALMOLIVE CO CL 0001576945 Tsourapas Panagiotis C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK NY 10022 1 Grp Pres, Eur& Developing Mkts 0 Common Stock 2023-05-10 4 M 0 13698.0000 73.0000 A 20604.0000 D Common Stock 2023-05-10 4 S 0 13698.0000 81.0760 D 6906.0000 D Common Stock 2023-05-10 4 S 0 2404.0000 81.0063 D 822.0000 I By Spouse Common Stock 4141.0000 I By Issuer's 401(k) Plan Trustee Common Stock 59282.0000 I By Trust Stock Option (Right to Buy) 73.0000 2023-05-10 4 M 0 13698.0000 0.0000 D 2023-09-25 Common Stock 13698.0000 0.0000 D Exercise of stock options awarded under the issuer's incentive compensation plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $81.07 to $81.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $81.00 to $81.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date. /s/ Kristine Hutchinson, Attorney-in-Fact 2023-05-12